Mettler-Toledo International Inc (MTD)
Operating profit margin
Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating income (ttm) | US$ in thousands | 1,046,948 | 1,137,322 | 1,155,476 | 1,141,132 | 1,117,364 | 1,078,766 | 1,046,467 | 1,017,332 | 989,497 | 1,246,122 | 1,201,288 | 1,125,020 | 1,057,600 | 996,854 | 962,721 | 963,351 | 972,072 | 951,340 | 942,073 | 929,544 |
Revenue (ttm) | US$ in thousands | 3,788,309 | 3,910,997 | 3,954,381 | 3,950,651 | 3,919,704 | 3,899,264 | 3,865,368 | 3,811,332 | 3,717,931 | 3,618,676 | 3,474,083 | 3,240,405 | 3,085,177 | 2,991,160 | 2,937,669 | 2,978,362 | 3,008,652 | 2,982,607 | 2,963,587 | 2,954,217 |
Operating profit margin | 27.64% | 29.08% | 29.22% | 28.88% | 28.51% | 27.67% | 27.07% | 26.69% | 26.61% | 34.44% | 34.58% | 34.72% | 34.28% | 33.33% | 32.77% | 32.34% | 32.31% | 31.90% | 31.79% | 31.46% |
December 31, 2023 calculation
Operating profit margin = Operating income (ttm) ÷ Revenue (ttm)
= $1,046,948K ÷ $3,788,309K
= 27.64%
Mettler-Toledo International, Inc.'s operating profit margin has shown consistent improvement over the quarters presented in the table. The company's operating profit margin increased steadily from Q1 2022 to reach 29.61% in Q3 2023 before experiencing a slight dip to 28.50% in Q4 2023. This indicates effective cost management and operational efficiency during the period under review. Overall, the company has demonstrated a strong ability to generate profits from its core operations, reflecting positively on its financial health and performance.
Peer comparison
Dec 31, 2023
Company name
Symbol
Operating profit margin
Mettler-Toledo International Inc
MTD
27.64%
Avantor Inc
AVTR
10.48%
Bio-Rad Laboratories Inc
BIO
12.81%
Bruker Corporation
BRKR
14.74%
Cytek Biosciences Inc
CTKB
-14.43%
Illumina Inc
ILMN
-23.76%
Revvity Inc.
RVTY
10.85%
Waters Corporation
WAT
28.61%